title: Analysis of nifedipine absorption from soft gelatin capsules using PBPK modeling and biorelevant dissolution testing.
abstract: Delayed absorption of nifedipine when administered as a 20 mg immediate release soft gelatin capsule to fasted volunteers has been reported. Physiologically based pharmacokinetic (PBPK) modeling and in vitro dissolution data were used to explore our hypothesis that at high doses of nifedipine it precipitates in the stomach. Plasma concentration-time profiles following different doses of nifedipine were simulated using commercial PBPK software and compared to in vivo data. In vitro dissolution tests were performed with Adalat 10 mg capsules in different volumes of fasted state simulated gastric fluid (FaSSGF). The discrepancy in plasma concentration-time profiles between the different nifedipine doses could be well simulated, assuming protracted dissolution for the 20 mg dose. Nifedipine release from one Adalat 10 capsule in 250 or 500 mL FaSSGF was completed within 15 min whereas when release from two capsules, corresponding to 20 mg nifedipine, was studied in 250 mL FaSSGF, a maximum of about 75% drug dissolved was observed after 15 min followed by a decline in the % dissolved to a final value of approximately 40%. Based on the in silico and in vitro results it can be concluded that the observed prolongation in nifedipine absorption following the 20 mg dose was likely caused by nifedipine precipitation in human stomach.
authors.affiliation: Institute of Pharmaceutical Technology, Johann Wolfgang Goethe University, 60438 Frankfurt am Main, Germany.
authors.forename: Kirstin
authors.initials: K
authors.lastname: Thelen
authors.forename: Ekarat
authors.initials: E
authors.lastname: Jantratid
authors.forename: Jennifer B
authors.initials: JB
authors.lastname: Dressman
authors.forename: Jörg
authors.initials: J
authors.lastname: Lippert
authors.forename: Stefan
authors.initials: S
authors.lastname: Willmann
mesh_terms: D000042:Absorption; D002214:Capsules / Q000737:chemistry*; D002986:Clinical Trials as Topic; D005780:Gelatin; D006801:Humans; D009543:Nifedipine / Q000008:administration & dosage*; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D055585:Physical Phenomena; D012106:Research; D012984:Software; D013270:Stomach
chemical_list: D002214:Capsules; D004364:Pharmaceutical Preparations; D005780:Gelatin; D009543:Nifedipine